Minotab (Minocycline Hydrochloride)

Minocycline blocks bacterial protein synthesis by binding to the 30S ribosomal subunit. This prevents the addition of amino‑acyl tRNA to the growing peptide chain, halting bacterial growth and producing a bacteriostatic effect against a broad range of Gram‑positive and Gram‑negative organisms.

The specific dose and duration of Minotab are determined by the prescribing clinician based on the infection type, severity, patient age, weight, and renal or hepatic function. Typical adult regimens range from 100 mg to 200 mg once or twice daily, but exact instructions must come from a qualified health professional.

Minotab is classified as Pregnancy Category D, indicating evidence of risk to the fetus. It should be used only when the potential benefit justifies the risk. Minocycline is excreted in breast milk and may affect the infant; breastfeeding mothers should discuss alternatives with their healthcare provider.

To request Minotab, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Minotab (minocycline) offers a longer half‑life and better tissue penetration than doxycycline, allowing once‑ or twice‑daily dosing. It also has a broader spectrum against certain resistant strains but carries a higher risk of vestibular side effects and skin discoloration. Choice of tetracycline depends on infection type, patient tolerance, and physician preference.

Store Minotab below 25 °C in its original packaging. Keep the tablets away from moisture, direct sunlight and excessive heat. Do not refrigerate or freeze. Ensure the container is tightly closed to maintain product stability throughout its shelf life.

Minotab is taken orally, usually with a full glass of water. It can be taken with or without food, but if gastrointestinal upset occurs, a light meal may help. Tablets should be swallowed whole; they must not be crushed, chewed, or split unless specifically instructed by a healthcare professional.

Serious adverse events include Stevens‑Johnson syndrome or toxic epidermal necrolysis, severe hepatic injury, anaphylactic reactions, and intracranial hypertension. Patients should seek immediate medical attention if they develop rash, blistering, jaundice, difficulty breathing, severe headache, or visual disturbances while on Minotab.

Minotab is contraindicated in individuals with known hypersensitivity to minocycline or other tetracyclines, pregnant women unless clearly needed, and nursing mothers due to drug excretion in milk. Caution is advised for patients with severe hepatic or renal impairment, and it should be avoided in children under eight years of age because of permanent tooth discoloration.